Published on in Vol 23, No 7 (2021): July
1 Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
2 Department of Medicine III, RWTH University Hospital Aachen, Aachen, Germany
3 National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
4 Department of Dermatology, University Hospital of Mannheim, Mannheim, Germany
5 Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
6 Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
7 Department of Dermatology, University Hospital of Kiel, Kiel, Germany
8 Department of Dermatology and Allergology, Ludwig Maximilian University of Munich, Munich, Germany
9 Department of Dermatology, Venereology and Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany
10 Dermatopathology Laboratory, Friedrichshafen, Germany
11 Department of Dermatology, University Hospital Erlangen, Erlangen, Germany
12 Department of Dermatology, University Hospital of Regensburg, Regensburg, Germany
13 Department of Dermatology, University Hospital Essen, Essen, Germany
14 Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
15 Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany
16 Faculty of Medicine, Medical Center, Otto-von-Guericke-University, Magdeburg, Germany
*these authors contributed equally